|
IAH appoints new Head of Epidemiology
March 03, 2003The Institute for Animal Health is pleased to announce that Dr Matthew Baylis has been appointed as Head of the Division of Epidemiology. Dr Baylis will take charge of a re-structured division responsible for experimental epidemiology and mathematical modelling of a number of infectious diseases across the Institute's three laboratories at Compton, Edinburgh and Pirbright.
Dr Baylis joined the Institute in 1993 as a postdoctoral researcher, and became a research group leader in 2000. During this time he has made a significant impact in the development of mathematical models to predict the spread of BSE, scrapie, bluetongue, and African horse sickness.
IAH Director Professor Paul-Pierre Pastoret said, "I am delighted to be able to appoint Dr Baylis to this senior position within IAH. Matthew's expertise in mathematical modelling will add a new dimension to the Institute's international reputation in disease surveillance and control."
Research within the epidemiology division will focus on how viruses, including foot-and-mouth disease (FMD), evolve to form new strains; the role of midges in the spread of diseases such as bluetongue; the spread of scrapie in UK sheep; and tracking and predicting the spread of diseases by mathematical modelling.
Dr Baylis said, "I am looking forward to leading the epidemiology division, especially at a time when strategies for dealing with future outbreaks of infectious diseases have become a major policy issue both within the UK and abroad."
Institute for Animal Health
Infectious Diseases News and Current Infectious Diseases Events RSSUTSA/UTHSCSA publish results on bio-threat agent
Researchers at The University of Texas at San Antonio (UTSA) South Texas Center for Emerging Infectious Diseases and The University of Texas Health Science Center at San Antonio (UTHSCSA) have identified a cell type believed to play a role in controlling the early infectious process against Francisella tularensis, a respiratory pathogen and bioterrorism agent that is the cause of tularemia.
Cancer 'cure' in mice to be tested in humans
Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.
Overcrowding and understaffing in hospitals increases levels of MRSA infections
A review article authored by a University of Queensland academic has found overcrowding and understaffing in hospitals are two key factors in the transmission of MRSA (Meticillin - Resistant Staphylococcus Aureus) infections worldwide.
Diversity among bird populations found to reduce threat of West Nile virus
A biologist and undergraduate student have discovered that what's good for an area's bird population is also good for people living nearby.
Laser Surgery Probe Targets Individual Cancer Cells
Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser "microscalpel" that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases.
New findings on immune system in amphibians
Krakow/Halle. Major Histocompatibility Complex (MHC) genes produce proteins that are crucial in fighting pathogen assault. Researchers from the Jagiellonian University in Krakow and from the Helmholtz Centre for Environmental Research (UFZ) characterized genetic variation and detected more than one MHC class II locus in a tailed amphibian.
LIAI Researchers Discover New Cellular Mechanism That Will Significantly Advance Vaccine Development
La Jolla Institute for Allergy & Immunology (LIAI) scientists have discovered one for the textbooks. Their finding, reported Friday in the scientific journal Immunity, illuminates a new, previously unknown mechanism in how the body fights a virus.
New study shows potential to treat or prevent viral cancers
A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy.
How Montezuma gets his revenge
Every year, about 500 million people worldwide are infected with the parasite that causes dysentery, a global medical burden that among infectious diseases is second only to malaria.
Unexpected finding of molecule's dual role in mice may open new avenue to cholesterol reduction
Researchers have discovered an unknown regulator of fat and cholesterol production in the liver of mice, a significant finding that could lead to new therapies for lowering unhealthy blood levels of cholesterol and fats.
More Infectious Diseases News Articles
 | Cure Unknown: Inside the Lyme Epidemic by Pamela Weintraub |
 | The Hot Zone: A Terrifying True Story by Richard Preston |
 | The Ghost Map: The Story of London's Most Terrifying Epidemic--and How It Changed Science, Cities, and the Modern World by Steven Johnson |
 | Sustaining Life: How Human Health Depends on Biodiversity |
 | The Lyme Disease Solution by Kenneth B. Singleton |
 | Beating Lyme: Understanding and Treating This Complex and Often Misdiagnosed Disease by Constance A. Bean, Lesley Ann Fein |
 | The Demon in the Freezer by Richard Preston |
 | Control Of Communicable Diseases Manual (Control of Communicable Diseases Manual) (Control of Communicable Diseases Manual) by David L. Heymann |
 | Infections and Inequalities: The Modern Plagues by Paul Farmer |
 | Guide to the Dissection of the Dog by Howard Evans, Alexander Delahunta |
| © 2008 BrightSurf.com |